CANNAPHARMARX, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2012
FY2011
FY2010
Asset Breakdown FY2019
Total Assets: $16.0M
Liabilities Breakdown FY2019
Total Liabilities: $11.2M
Asset Breakdown
Total Assets: $16.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.5K | 0.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.5M | 9.6% |
| Goodwill | $6.4M | 39.8% |
| Intangible Assets | $1.8M | 11.5% |
| Other Assets | $6.3M | 39.1% |
Liabilities Breakdown
Total Liabilities: $11.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $902.9K | 8.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $10.3M | 91.9% |